DNMT3A and autoimmune disease: Recently, CHIP—with the most common mutations in DNMT3A (29.5%)—was associated with an increased risk for autoimmune diseases (OR 6.6, 95% CI 1.7–30) in patients undergoing hip arthroplasty (29).